Bio
Dr Tony Raven joined Cambridge Enterprise as Chief Executive in December 2011, following an outstanding history of entrepreneurial success. Previously Director of Research & Innovation Services at University of Southampton, Dr Raven helped establish Southampton’s international reputation, creating a portfolio of 11 spin-out companies with four listings on the London Stock Exchange. After graduating with a First in physics from Manchester University, he obtained his MSc and Dphil from University of Oxford. He worked at Rutherford Appleton Laboratories and Osaka University before joining Cambridge-based PA Consulting in 1983. In 1985 he was a founder of Summit Technology, the market leader in laser refractive surgery, which was acquired by Nestle Alcon in 2000 for $893 million. In 1987 he co-founded Cambridge-based Sagentia Group plc, a technical and management consultancy firm which is listed on the London Stock Exchange. In 1991 he founded Diomed Inc, a pioneer and world leader in therapeutic medical diode lasers, and served as CEO and Deputy Chairman until 2000. Dr Raven is a Fellow of the Institute of Physics and a Member of the Institute of Directors.
Career
![]() |
Cambridge EnterpriseThe commercialisation arm of the University of Cambridge.Email: [email protected] |
||
![]() |
Cambridge Innovation Capital PLCCIC was established with the support of the University of Cambridge (UC) to invest in high growth early-stage technology spinouts from UC and the area |